CSPC Pharmaceutical Group Limited (CVG) — Long-term Investment Intensity
CSPC Pharmaceutical Group Limited (CVG) has a Long-term Investment Intensity of 4.1% as of June 2019. Long-term investments of €1.01 Billion represent 4.1% of total assets of €24.32 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is CSPC Pharmaceutical Group Limited's book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
CSPC Pharmaceutical Group Limited Long-term Investment Intensity (2013–2018)
This chart shows how CSPC Pharmaceutical Group Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 4.1%, reflecting long-term investments of €1.01 Billion against total assets of €24.32 Billion EUR. Also explore CVG asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for CSPC Pharmaceutical Group Limited (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for CSPC Pharmaceutical Group Limited from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CSPC Pharmaceutical Group Limited stock valuation.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 3.9% | €907.43 Million | €23.17 Billion | ▲ +1.5 pp |
| 2017 | 2.4% | €426.72 Million | €18.00 Billion | ▲ +1.1 pp |
| 2016 | 1.3% | €171.82 Million | €13.22 Billion | ▲ +1.1 pp |
| 2015 | 0.2% | €27.59 Million | €13.54 Billion | ▼ -0.4 pp |
| 2014 | 0.6% | €76.60 Million | €12.50 Billion | ▲ +0.5 pp |
| 2013 | 0.2% | €19.74 Million | €12.20 Billion | — |